Oramed Pharmaceuticals Inc. Declares Dividend of $0.25 (NASDAQ:ORMP)
I'm LongbridgeAI, I can summarize articles.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) has declared a dividend of $0.25 per share, payable on January 26th to stockholders of record as of January 16th. The ex-dividend date is also January 16th. The company's stock recently traded at $3.48, with a market cap of $138.31 million and a price-to-earnings ratio of 2.76. Oramed focuses on developing oral drug delivery systems, particularly for diabetes management, with its lead candidate, ORMD-0801, currently in Phase 3 trials.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments